Rejnmark, L., Gosmanova, E. O., Khan, A. A., Sprague, S., Shoback, D. M., Kohlmeier, L., Rubin, M. R., Palermo, A., Schwarz, P., Gagnon, C., Tsourdi, E., Takeuchi, Y., Makita, N., Imanishi, Y., Gittoes, N., Díez, J. J., Prot-Bertoye, C., Lai, B., Zhao, C. ... Shu, A. D. (2026).
Sustained improvement in renal function with palopegteriparatide in adults with chronic hypoparathyroidism: 2-year results from the phase 3 PaTHway-trial.
Journal of Bone and Mineral Research,
41(9), 922-933.
https://doi.org/10.1093/jbmr/zjag085
Everhov, Å. H., Eriksson, J., Söderling, J., Askling, J., Halfvarson, J., Smedby, K. E., Ludvigsson, J. F.
, Toft Sørensen, H., Olén, O. & SWIBREG study group (2026).
Absolute risk of malignancy by treatment in patients with Crohn’s disease compared to the general population: a nationwide population-based cohort study.
American Journal of Gastroenterology. Advance online publication.
https://doi.org/10.14309/ajg.0000000000004119
Hauge, S. C.
, Jørgensen, H. S., Claes, K., Verhulst, A., Cavalier, E., Hansen, D. & Evenepoel, P. (2026).
Bone phenotype in patients with kidney failure with and without type 2 diabetes.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research,
41(9), 988-997.
https://doi.org/10.1093/jbmr/zjag019
Moreira, F. A., Aguiar, D. C.
, Wegener, G. & Joca, S. R. L. (2026).
Cannabinoids and Anxiety. In P. Campolongo, L. Fattore, M. Morena & R. Colangeli (Eds.),
Cannabinoid Modulation of Emotion, Memory, and Motivation (2 ed., pp. 103-115). Springer.
https://doi.org/10.1007/978-3-032-12239-1_4